Clinical Trials

“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database


0 +

Active Studies

0 +

Active Studies
Cancer Types


Cancer Types

Why join a clinical trial?

Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.

New clinical trials added on Mar 24, 2023

  • SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

    NCT Number : NCT05775146

  • Cancer Survivorship in Hematologic Malignancies

    NCT Number : NCT05780411

  • Improving Access to Lung Cancer Clinical Trials

    NCT Number : NCT05780164

  • A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

    NCT Number : NCT05774951

  • Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression

    NCT Number : NCT05779553

  • Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences

    NCT Number : NCT05778045

  • Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

    NCT Number : NCT05780567

  • Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

    NCT Number : NCT05776524

  • Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

    NCT Number : NCT05777603

  • Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm

    NCT Number : NCT05779631

  • Implantable Microdevice for TNBC - Pilot Study

    NCT Number : NCT05774886

  • A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

    NCT Number : NCT05775549

  • IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

    NCT Number : NCT05780307

  • Lung Cancer, Exercise and Force Development

    NCT Number : NCT05778136

  • Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

    NCT Number : NCT05775406

  • Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation

    NCT Number : NCT05774678

  • Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study

    NCT Number : NCT05776147

  • Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

    NCT Number : NCT05775471

  • Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

    NCT Number : NCT05775159

  • Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

    NCT Number : NCT05779943

  • Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation

    NCT Number : NCT05778149

  • UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

    NCT Number : NCT05775666

  • Fast MRI Compared to Routine Clinical MRI in Children With Brain Tumor

    NCT Number : NCT05776602

  • Cryoablation+Ipilimumab+Nivolumab in Melanoma

    NCT Number : NCT05779423

  • Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

    NCT Number : NCT05780684

  • Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)

    NCT Number : NCT05778097

  • A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

    NCT Number : NCT05780034

  • Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC

    NCT Number : NCT05775796

  • A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

    NCT Number : NCT05779163

  • Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

    NCT Number : NCT05776979

  • Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients

    NCT Number : NCT05778708

  • Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

    NCT Number : NCT05774964

  • IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

    NCT Number : NCT05774873

  • Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression

    NCT Number : NCT05777278

  • A Phase 1/2 Study CB-103 With or Without Venetoclax in Patients With NOTCH ACC

    NCT Number : NCT05774899

  • COACH-Cog Intervention Adaptation Focus Groups

    NCT Number : NCT05775991

  • NKG2D CAR-NK & Ovarian Cancer

    NCT Number : NCT05776355

  • Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

    NCT Number : NCT05776758

  • A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

    NCT Number : NCT05778825

  • ARtificial Intelligence for Gross Tumour vOlume Segmentation

    NCT Number : NCT05775068

  • The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp

    NCT Number : NCT05776381

  • Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

    NCT Number : NCT05776875

  • Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer

    NCT Number : NCT05775900

  • PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer

    NCT Number : NCT03638297

  • Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer

    NCT Number : NCT05775822

  • A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

    NCT Number : NCT05775575

  • Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

    NCT Number : NCT05778955

  • Mesothelin-CAR-T Cells Against Cancers

    NCT Number : NCT05779917

  • Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

    NCT Number : NCT05775458

  • The Effects of Multi-Psycho-Oncology Care Courses

    NCT Number : NCT05776680


    NCT Number : NCT05775926

  • A Study of RO7247669 Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

    NCT Number : NCT05775289

  • Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma

    NCT Number : NCT05776667

  • Exploratory Evaluation of the Functional/Emotional Life Characteristics During the First Year of Ongoing Endocrine Adjuvant Treatment With Aromatase Inhibitors in Breast Cancer Patients With Reduced Bone Mineral Density

    NCT Number : NCT05779566

  • Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy

    NCT Number : NCT05777824

  • SMC Radiation Oncology Breast Cancer Cohort Study

    NCT Number : NCT05775757

  • Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery

    NCT Number : NCT05779670

  • RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists

    NCT Number : NCT02112565

  • Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

    NCT Number : NCT05776407

  • Telerehabilitation in Hemato-oncological Survivors

    NCT Number : NCT05779605

  • Effect of CaviionTM Precaution Medical Adhesive-related Skin Injury in Tumor Patients With PICC Catherizaion

    NCT Number : NCT05776732

  • Clinical Trial for the Validation of AR Based Neuronavigation System

    NCT Number : NCT05776706

  • Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment

    NCT Number : NCT05774990

  • A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

    NCT Number : NCT05775523

  • PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung Cancer, EUCLID Trial

    NCT Number : NCT05775939

  • A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

    NCT Number : NCT05780294

  • A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

    NCT Number : NCT05779592

  • Effect of Mirabegron on Promoting Brown Adipose Tissue Activation

    NCT Number : NCT05779514

  • Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

    NCT Number : NCT05780372

  • Prognostic and Predictive Markers of Treatment Response in Patients With Pancreatic Adenocarcinoma

    NCT Number : NCT05776342

  • Effects of Adding Dexamethasone Plus Ketamine to Bupivacine in Serrtatus Plane Block

    NCT Number : NCT05775393

  • Epidemiology of Helicobacter Pylori Infection in Moscow

    NCT Number : NCT05775120

  • A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

    NCT Number : NCT05777993

  • A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

    NCT Number : NCT05775094

  • Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

    NCT Number : NCT05777707

  • The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

    NCT Number : NCT05778253

  • Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis

    NCT Number : NCT05778929

  • The Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's Disease

    NCT Number : NCT05779137

  • A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

    NCT Number : NCT05775874

  • Oxygen Nanobubble Drink Impact on Exercise in Elite Athletes

    NCT Number : NCT05777642

  • MUSic Therapy In Complex Specialist Neurorehabilitation

    NCT Number : NCT05777499

  • COVID-19 Infection in Patients With Hepatocellular Carcinoma

    NCT Number : NCT04367805

  • Serratus Plain Block Versus Paravertebral Block Versus Serratus Plain Block and Paravertebral Block for Postoperative Pain Following Thoracoscopic Surgery

    NCT Number : NCT04222010

  • Study of Different Gating Techniques for PET Image of Lung and Liver Lesions

    NCT Number : NCT05779865

  • Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC

    NCT Number : NCT05775419

  • Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment

    NCT Number : NCT05780073

  • Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

    NCT Number : NCT05779930

  • Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population

    NCT Number : NCT05778851

  • L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

    NCT Number : NCT05775705

  • Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis

    NCT Number : NCT05776940

  • R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

    NCT Number : NCT05777369

  • Mindful Parenting - A Single Case Experimental Design Study

    NCT Number : NCT05779527

  • Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2

    NCT Number : NCT05778006

  • Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

    NCT Number : NCT05782985

  • Role of Surgery in Management of Pineal Region Tumors in Children

    NCT Number : NCT05781984

  • Psychoeducation Intervention for Caregivers of Children With Cancer

    NCT Number : NCT05783310

  • Self-collected Vaginal and Urine Samples in HIV-positive Women

    NCT Number : NCT05783167

  • MSLN-targeted CAR-T Cells in Solid Tumors.

    NCT Number : NCT05783089

  • Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

    NCT Number : NCT05781217

  • Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

    NCT Number : NCT05783323

  • The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

    NCT Number : NCT05780814

  • IV Ibuprofen vs Ketorolac in Post Operative Pain in Colorectal Cancer Surgeries in Obese Patient

    NCT Number : NCT05782608

  • POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC

    NCT Number : NCT05782361

  • Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

    NCT Number : NCT05782426

  • A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors

    NCT Number : NCT05781555

  • A Phase I Clinical Study of the Safety, Tolerability,Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors

    NCT Number : NCT05781048

  • Open-Label, Multicenter, Phase 1/1b Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

    NCT Number : NCT05783622

  • Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in the Primary Prevention of Catheter-related Endoluminal Infection in Paediatric Oncology

    NCT Number : NCT05781295

  • Developing a MRI-based Deep Learning Model to Predict MMR Status

    NCT Number : NCT05783986

  • Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

    NCT Number : NCT05784428

  • A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer

    NCT Number : NCT05780736

  • Multi-Cancer Early Detection (MCED) of Firefighters

    NCT Number : NCT05780957

  • Multiparametric Magnetic Resonance Imaging Performance in Detection of Occult Muscle Invasion in Urinary Bladder Cancer

    NCT Number : NCT05783271

  • Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer (CASTLE-08)

    NCT Number : NCT05781074

  • A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia

    NCT Number : NCT05780879

  • Advanced Data-Aided Medicine Part Lung Cancer

    NCT Number : NCT05783024

  • The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.

    NCT Number : NCT05781633

  • Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)

    NCT Number : NCT05782465

  • Epcoritamab and Rituximab for First-line Follicular Lymphoma

    NCT Number : NCT05783609

  • Patient-centered Breast Cancer Teleprehabilitation

    NCT Number : NCT05782504

  • Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

    NCT Number : NCT05783596

  • Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

    NCT Number : NCT04030260

  • SBRT Plus vNKT for Pancreatic Cancer

    NCT Number : NCT05783076

  • A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

    NCT Number : NCT05781386

  • Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval

    NCT Number : NCT00657878

  • A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.

    NCT Number : NCT01745965

  • Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

    NCT Number : NCT05781308

  • Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)

    NCT Number : NCT05784142

  • STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study

    NCT Number : NCT00526396

  • A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

    NCT Number : NCT05783921

  • Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer

    NCT Number : NCT01815242

  • A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol

    NCT Number : NCT01817452

  • A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors

    NCT Number : NCT05781360

  • Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)

    NCT Number : NCT05784311

  • Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma (RADIAN)

    NCT Number : NCT05784012

  • A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response

    NCT Number : NCT02214381

  • Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

    NCT Number : NCT04175912

  • Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

    NCT Number : NCT05783544

  • Adapting a Betel Quid Cessation Program for a High-risk Community in Malaysia and Evaluating Its Effectiveness

    NCT Number : NCT05782166

  • Prediction of Delayed Toxic Cardiomyopathy in Children

    NCT Number : NCT05781672

  • Impact of Systematic Shaving on Margins

    NCT Number : NCT05782686

  • Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    NCT Number : NCT05781152

  • Digital Voice Analysis as a Measure of Frailty and Distress

    NCT Number : NCT05783401

  • Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

    NCT Number : NCT05781321

  • Use of Virtual Reality for Surgical Planning in Neuroblastoma

    NCT Number : NCT05781919

  • Surgeons' Mental Distress and Risks After Severe Complications Following Radical Gastrectomy

    NCT Number : NCT05782205

  • A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection

    NCT Number : NCT05781581

  • Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

    NCT Number : NCT05781841

  • Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

    NCT Number : NCT05784415

  • Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

    NCT Number : NCT05782400

  • Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients

    NCT Number : NCT05783518

  • Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

    NCT Number : NCT05780905

  • Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

    NCT Number : NCT05782777

  • Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

    NCT Number : NCT05781568

  • Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions

    NCT Number : NCT05783908

  • To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

    NCT Number : NCT05783570

  • The Effect of Brain Breaks on People With Mental Health Problems

    NCT Number : NCT05783674

  • Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions

    NCT Number : NCT04172922

  • Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC

    NCT Number : NCT05781958

  • Real World Data on Ibrutinib Use in PCNSL Rel/Ref

    NCT Number : NCT05782374

  • Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

    NCT Number : NCT05782959

  • Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas

    NCT Number : NCT05783973

  • Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma

    NCT Number : NCT05783882

  • C-CAR066 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

    NCT Number : NCT05784441

  • The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion

    NCT Number : NCT05781659

  • Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes

    NCT Number : NCT05782127

  • A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom

    NCT Number : NCT05782764

  • A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection

    NCT Number : NCT05784129

Want alerts of new clinical trials into your email inbox? Subscribe today

Find a Trial

Enter a few details below to get started and we'll help you match up with active clinical trials

Cancer Details

8578 Trials found

Cancer Details

Eligibility Criteria


OncoPower Clinical Trial Features

OncoPower Clinical Trial Features


Clinical Trial Matching

Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you


Eligiblity Verification

We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria


Reimbursement Options

Our team will connect you with financial resources available to clinical trial participants


Trial Sponsor Coordination

OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial

FAQs For Patients

Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.

There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).

Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.

You are able to leave a clinical trial at any time, for any reason.

Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.

Create Your Free Account Today

Begin offering a comprehensive digital experience for your patients.